Viewing Study NCT04398459


Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2025-12-25 @ 9:38 PM
Study NCT ID: NCT04398459
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-25
First Post: 2020-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module